Paragon Genomics
3521 Investment Blvd
Suite 1
Hayward
CA
94545
United States
Website: http://www.paragongenomics.com/
18 articles about Paragon Genomics
-
Paragon Genomics Partners with Devyser to Expand CleanPlex® Technology Distribution in Italy
3/1/2023
Paragon Genomics announced a partnership with Devyser, a world leader in diagnostic kits and solutions for advanced DNA testing, to distribute its CleanPlex® products and technology in Italy, with the option to expand into additional territories.
-
Apogee Therapeutics sprang onto the immunology/inflammatory scene Wednesday heavy on capital but light on salient details of the pipeline.
-
Paragon Genomics Unveils New CleanPlex® Emerging Variant Add-on V2 for Enhanced Identification of Omicron and Emerging SARS-CoV-2 Variants
2/22/2022
Paragon Genomics, Inc. reported that its CleanPlex® SARS-CoV-2 Research and Surveillance Panels for viral detection, mutation analysis, variant tracking and epidemiological research have continued to play an important role in accurately identifying COVID-19 variants of interest and concern, including early identification of the Delta and Omicron variants in patient samples and in wastewater.
-
New Publications Confirm Paragon Genomics CleanPlex® SARS-CoV-2 Panel Enables Accurate Identification of Variants of Concern
7/28/2021
Paragon Genomics, Inc. reported publication of three scientific studies confirming that its CleanPlex® SARS-CoV-2 Research and Surveillance Panel for viral detection, mutation analysis, variant tracking and epidemiological research accurately identifies important COVID-19 variants, such as the B.1.1.7 Alpha variant and the B.1.617.2 Delta variant, major variants of concern that have been implicated in surges of COVID-19 infections worldwide.
-
Paragon Genomics Highlights Year of Rapid Growth Fueled by Broad Acceptance of Its CleanPlex® SARS-CoV-2 Research and Surveillance Products
4/27/2021
Paragon Genomics, Inc., a leader in amplicon-based target enrichment solutions for next-generation sequencing (NGS) and precision medicine, today reported that its CleanPlex® SARS-CoV-2 panels for viral detection, mutation analysis, variant tracking and epidemiological research have achieved broad acceptance and rapid sales growth since their introduction a year ago.
-
Paragon Genomics Expands Portfolio of CleanPlex® SARS-CoV-2-Related NGS Tests
10/14/2020
New CleanPlex® ACE2 & TMPRSS2 Panel Assesses Differences in Patients' Genetic Susceptibility to COVID-19 Infection and to Developing Severe Disease
-
Paragon Genomics Readies Higher Throughput Version of Its Popular CleanPlex® SARS-CoV-2 NGS Panel Amid Growing Need for Large-Scale COVID-19 Testing
7/8/2020
Multiplexed Target Enrichment Panel Sequences the Entire Viral Genome for High Coverage of Target Regions, Better Accuracy and Mutation Tracking
-
A summary of daily biopharma industry news. Please check out stories that are trending on March 26, 2020.
-
Paragon Genomics Introduces CleanPlex® SARS-CoV-2 NGS Panel for Research and Surveillance of COVID-19 Coronavirus
3/19/2020
Highly Multiplexed Target Enrichment Panel Covers Entire Genome of the New Coronavirus to Facilitate Complete Genome Sequencing and Support Epidemiological Studies
-
Paragon Genomics to present at Biotech Showcase™ 2020
1/7/2020
Paragon Genomics, Inc., a leader in amplicon-based target enrichment solutions for next-generation sequencing (NGS) and precision medicine, today announced that it will present at Biotech Showcase™ 2020, to be held January 13–15, 2020 at the Hilton San Francisco Union Square. Paragon Genomics CEO Tao Chen will give a corporate presentation and meet with investors.
-
Paragon Genomics Introduces CleanPlex® Cftr Panel And Unveils New Fusion Detection Methods At AMP 2019 Annual Meeting
11/4/2019
New CleanPlex® CFTR Targeted Resequencing Assay Simplifies Evaluation of Somatic and Germline CFTR Mutations and Variants, Enabling Comprehensive Assessment in Cystic Fibrosis with Reduced Sample Input, Greater Ease of Use and more Efficient Workflow
-
Paragon Genomics Introduces New CleanPlex® Hereditary Cancer Panel V2 At American Society For Human Genetics 2019 Annual Meeting
10/14/2019
Improved Version of Hereditary Cancer Panel Facilitates Same-Day Risk Assessment of Multiple Hereditary Cancers with Reduced Sample Input, Greater Ease of Use and 3-Hour Workflow
-
Paragon Genomics Establishes Subsidiary to Market Its Advanced CleanPlex® NGS Target Enrichment Solutions in China
9/16/2019
Paragon Genomics, Inc. announced it has established a subsidiary in China to market its CleanPlex® products to the rapidly growing Chinese market.
-
Paragon Genomics Partners With MGI Tech To Distribute Its CleanPlex® NGS Target Enrichment Panels Worldwide
1/6/2019
Subsidiary of BGI Group Will Distribute CleanPlex® NGS Target Enrichment Panels Optimized for Its MGISEQ and BGISEQ Sequencing Platforms in All Territories Outside the U.S.
-
Paragon Genomics Partners Its Ultra-High Multiplexed Target Enrichment Technology With SOPHiA GENETICS For Comprehensive Genomic Solutions
10/31/2018
Universal SOPHiA AI Platform Now Includes Paragon Genomics' Accurate and Sensitive CleanPlex® NGS Target Enrichment Technology for Its Rapidly-Growing Global Community of Cancer Centers
-
Paragon Genomics Introduces CleanPlex® UMI Panel for Ultrafast, Precise Analysis of Lung Cancer Hotspot Mutations at ASHG 2018
10/11/2018
First Product in Family of New CleanPlex® UMI NGS Panels that Deliver Highly Accurate Results in Detecting Low-Frequency Variants and Mutations for Liquid Biopsy and Other Applications
-
Paragon Genomics Launches ParagonDesigner™ Online Tool that MAKES IT Easy TO Design Custom CleanPlex® NGS Assays
9/20/2018
Custom NGS Panels for Illumina and Ion Torrent Platforms Use Paragon Genomics' CleanPlex® Technology that Enables Interrogation of a Large Number of Targets in a Single Assay
-
Paragon Genomics Raises $8 Million In Oversubscribed Series A Financing Round
9/12/2017